Participants sought: People with COPD for in-home nasal high flow air therapy

Participants with COPD sought for 8 day in-home study

EAGLE is a phase II trial to assess feasibility of using nasal high flow for breathlessness in participants with chronic obstructive pulmonary disease (COPD) who do not qualify for domiciliary long-term oxygen therapy.

We are seeking participants for our 8-day trial of in-home nasal high flow air therapy for COPD patients who experience breathlessness. The study aims to determine the effects of in-home nasal high flow air therapy on breathlessness, quality of life, and other symptom management. 

Contact Dr Amy Pascoe:

• email amy.pascoe@monash.edu 
• phone +61 3 9903 8930